Gynecologic Cancer, Surgical Complication, Surgical Site Infection
Conditions
Keywords
surgical site infection, gynecologic cancer
Brief summary
The purpose of this study is to investigate whether the use of a preoperative antibiotic bowel regimen is associated with a reduced risk of deep organ/space surgical site infection in gynecologic oncology surgery.
Detailed description
This is a retrospective chart review study. Patients who underwent scheduled intra-abdominal surgery with a WellSpan gynecologic oncologist will be identified and their chart reviewed for demographic data of age, race, BMI, comorbidities, and type of surgery. Those patients who had a deep organ/space surgical site infection within 30 days postoperatively will be identified. The numbers of these infections before and after August 2020, at which time all patients moving forwards were prescribed antibiotic bowel preparation, will then be statistically analyzed and compared to see if the institution of the antibiotic bowel preparation was associated with a reduction in surgical site infection.
Interventions
As an observational study, this notates patients who were diagnosed with a deep organ/space surgical site infection within 30 days of surgery
Sponsors
Study design
Eligibility
Inclusion criteria
\- Underwent scheduled intra-abdominal surgery with a WellSpan gynecologic oncologist
Exclusion criteria
* Unscheduled surgery * Intraoperative consult by a WellSpan gynecologic oncologist
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Surgical Site Infection Rates Associated with Antibiotic Bowel Prep | 2019-2021 | Rate of surgical site infection rate as associated with or without use of antibiotic bowel preparation |
Countries
United States